Aladorian

阿拉立安

Report date: 2025/04/09 16:36:49
NME

Base Information

Drug NameAladorian
Drug Alias Name阿多立安aladorianumS-36NaARM-036S-44121 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRyanodine receptor 3 modulatorsRyanodine receptor 2 modulatorsRyanodine receptor 1 modulators
TargetsRyanodine receptor 3Ryanodine receptor 2Ryanodine receptor 1
Therapy Area/IndicationsHeart FailureTachycardia, Ventricular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArmgo Pharma
China Registration ClassN/A

Develop Information

Active CompaniesArmgo PharmaLes Laboratoires Servier
Inactive CompaniesN/A
Active IndicationsHeart FailureTachycardia, Ventricular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG